glp 1 receptor drugs New GLP-1 Guidelines for Type 2 Diabetes in 2025 GLP-1 receptor agonists effective for

GLP-1 acts through its receptors located on immune cells, reducing the production of inflammatory cytokines and infiltration of immune cells in the tissues

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study

doi: 10.1097/HJH.0000000000001825 7 MallamaciFTripepiGD'ArrigoGBorrelliSGarofaloCStanzioneGet al

In contrast, no significant improvements in cardiovascular outcomes were observed with lixisenatide once daily in patients who had had a recent acute coronary event (28) or with exenatide once weekly among patients with or without established cardiovascular disease (29)

doi: 10.2146/ajhp110221